Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

There are expenses that Medicare won't cover in 2025, and it's important to find other ways to cover these costs.

It’s unclear what — if any — impact the Republican president’s executive order will have on millions of Americans who have ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

President Donald Trump signed an executive order on Monday aimed at lowering prescription drug prices in the U.S. Here's what ...

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United ...

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...